151 related articles for article (PubMed ID: 2796225)
1. [The role of radiotherapy in endocrine orbitopathy].
Feyerabend T; Richter E; Buschmann W; Becker W; Herbolsheimer M; Pingel B
Klin Monbl Augenheilkd; 1989 Jul; 195(1):1-6. PubMed ID: 2796225
[TBL] [Abstract][Full Text] [Related]
2. Echographic monitoring of response of extraocular muscles to irradiation in Graves' ophthalmopathy.
Erickson BA; Harris GJ; Lewandowski MF; Murray KJ; Massaro BM
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):651-60. PubMed ID: 7852132
[TBL] [Abstract][Full Text] [Related]
3. [Step-by-step treatment of progressive edematous-infiltrative ophthalmopathy in Graves' disease. Results of the treatment by plasmapheresis (stage II) and cobalt teletherapy of orbital tissues (stage III)].
Pilarska K; Czekalski S; Syrenicz A; Andrzejewska W; Krzystolik Z; Przerwa D; Marzecki Z; Daniel B; Osiński W
Endokrynol Pol; 1988; 39(5):237-44. PubMed ID: 3255604
[No Abstract] [Full Text] [Related]
4. Radiotherapy in the management of thyroid orbitopathy. Computed tomography and clinical outcomes.
Kao SC; Kendler DL; Nugent RA; Adler JS; Rootman J
Arch Ophthalmol; 1993 Jun; 111(6):819-23. PubMed ID: 8512483
[TBL] [Abstract][Full Text] [Related]
5. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone.
Bartalena L; Marcocci C; Chiovato L; Laddaga M; Lepri G; Andreani D; Cavallacci G; Baschieri L; Pinchera A
J Clin Endocrinol Metab; 1983 Jun; 56(6):1139-44. PubMed ID: 6341388
[TBL] [Abstract][Full Text] [Related]
6. Radiation retinopathy after orbital irradiation for Graves' ophthalmopathy.
Kinyoun JL; Kalina RE; Brower SA; Mills RP; Johnson RH
Arch Ophthalmol; 1984 Oct; 102(10):1473-6. PubMed ID: 6548374
[TBL] [Abstract][Full Text] [Related]
7. Indium-111-pentetreotide in Graves' disease.
Kahaly G; Görges R; Diaz M; Hommel G; Bockisch A
J Nucl Med; 1998 Mar; 39(3):533-6. PubMed ID: 9529305
[TBL] [Abstract][Full Text] [Related]
8. A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy.
Gorman CA; Garrity JA; Fatourechi V; Bahn RS; Petersen IA; Stafford SL; Earle JD; Forbes GS; Kline RW; Bergstralh EJ; Offord KP; Rademacher DM; Stanley NM; Bartley GB
Ophthalmology; 2001 Sep; 108(9):1523-34. PubMed ID: 11535445
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience of radiation therapy for Graves' ophthalmopathy.
Takahashi T; Mitsuhashi N; Nagashima H; Sakurai H; Murata O; Ishizeki K; Shimaya S; Hayakawa K; Niibe H
Radiat Med; 1996; 14(6):343-7. PubMed ID: 9132818
[TBL] [Abstract][Full Text] [Related]
10. [MR relaxation time measurements with and without selective fat suppression (SPIR) in endocrine orbitopathy].
Pauleit D; Schüller H; Textor J; Leutner C; Keller E; Sommer T; Träber F; Block W; Boldt I; Schild H
Rofo; 1997 Dec; 167(6):557-64. PubMed ID: 9465949
[TBL] [Abstract][Full Text] [Related]
11. Supervoltage orbital radiotherapy in 36 cases of Graves' disease.
Lloyd WC; Leone CR
Am J Ophthalmol; 1992 Apr; 113(4):374-80. PubMed ID: 1558110
[TBL] [Abstract][Full Text] [Related]
12. Effect of steroid pulse therapy with and without orbital radiotherapy on Graves' ophthalmopathy.
Ohtsuka K; Sato A; Kawaguchi S; Hashimoto M; Suzuki Y
Am J Ophthalmol; 2003 Mar; 135(3):285-90. PubMed ID: 12614743
[TBL] [Abstract][Full Text] [Related]
13. [Effects of external orbital radiotherapy on the oculomotor muscle in Graves disease].
Maalouf T; Angioi-Duprez K; Beckendorff V; Malet T; George JL
J Fr Ophtalmol; 1996; 19(12):748-54. PubMed ID: 9033899
[TBL] [Abstract][Full Text] [Related]
14. [Radiotherapy of endocrine orbital disease].
Sautter-Bihl ML; Heinze HG
Dtsch Med Wochenschr; 1989 Aug; 114(31-32):1214-20. PubMed ID: 2666083
[No Abstract] [Full Text] [Related]
15. Prognostic factors in the radiotherapy of Graves' ophthalmopathy.
Petersen IA; Kriss JP; McDougall IR; Donaldson SS
Int J Radiat Oncol Biol Phys; 1990 Aug; 19(2):259-64. PubMed ID: 2118493
[TBL] [Abstract][Full Text] [Related]
16. [Clinical evaluation of radiotherapy for endocrine ophthalmopathy].
Okada K; Oshitani T; Mieda C; Ogawa K; Maruta T; Ikeda Y; Suematsu T; Hirata Y; Obayashi K; Ishida T
Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Jun; 50(6):649-54. PubMed ID: 2235315
[TBL] [Abstract][Full Text] [Related]
17. Perspective--Part I: the Mayo Orbital Radiotherapy for Graves Ophthalmopathy (ORGO) study: lessons learned.
Bartley GB; Gorman CA
Ophthalmic Plast Reconstr Surg; 2002 May; 18(3):170-2. PubMed ID: 12021644
[No Abstract] [Full Text] [Related]
18. [The current role of radiotherapy in immunogenic exophthalmos].
Malinverni G; Giordana C; Rosmino C; Mancini A; Sala S
Radiol Med; 1994 Nov; 88(5):665-9. PubMed ID: 7824786
[TBL] [Abstract][Full Text] [Related]
19. Perspective--Part II: radiotherapy for Graves Orbitopathy: the Columbia University experience.
Kazim M
Ophthalmic Plast Reconstr Surg; 2002 May; 18(3):173-4. PubMed ID: 12021645
[No Abstract] [Full Text] [Related]
20. [Radiotherapy for Graves' ophthalmopathy].
Kuhnt T; Müller AC; Janich M; Gerlach R; Hädecke J; Duncker GI; Dunst J
Klin Monbl Augenheilkd; 2004 Nov; 221(11):915-21. PubMed ID: 15562354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
